COPD is associated with high levels of bacterial antibiotic resistance Source: Eur Respir J 2002; 20: Suppl. 38, 545s Year: 2002
Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD Year: 2020
The effect of erythromycin on the chronic lower airway infection by pseudomonas aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 640s Year: 2004
High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult patients with respiratory tract infections Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Amoxicillin concentrations in sputum in relation to betalactamase activity in COPD patients Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011
Pseudomonas aeruginosa drug susceptibility in patients hospitalized with COPD exacerbation and bronchiectasisSource: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001
Antibiotics reduce dual pathogen isolates more than single pathogen isolates following COPD exacerbation Source: Annual Congress 2009 - Exacerbations of COPD: new findings Year: 2009
Chronic use of azithromycin in CF is associated with a substantial increase in macrolide resistance of S. aureus and haemophilus Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs Year: 2006
Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD Source: Eur Respir J 2009; 34: 1066-1071 Year: 2009
Analysis of antibiotic resistance and enterococcal infections of low respiratory infection on patients in hospital Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003
Pseudomonas aeruginosa and antibiotic resistance in acute exacerbations of COPD (AECOPD) Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa Year: 2009
Bacteria, antibiotics and COPD Source: Eur Respir J 2001; 17: 995-1007 Year: 2001
Haemophilus influenzae in COPD patients with poorer lung function carry more antibiotic resistanceSource: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002
Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection in which Streptococcus pyogenes was isolated in sputum culture Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004
Severe exacerbations of chronic obstructive pulmonary disease (COPD) due to Pseudomonas aeruginosa : resistance to common antibiotics Source: Eur Respir J 2001; 18: Suppl. 33, 540s Year: 2001
Evolution of antimicrobial susceptibility of respiratory isolates in chronic obstructive pulmonary patients diagnosed of acquired community pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015
Genetic determinants of oropharyngeal streptococci antimicrobial resistance in COPD patients and asthma sufferers Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015
Antimicrobial profile and bacterial resistance in patients wit acute exacerbation of COPD, an Upper Egypt multicenters experience Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015
Characterisation and prevalence of macrolide resistance Streptococcus pneumoniae infecting pediatric patients Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood Year: 2009